DERMATITE ATÓPICA — A LINFOPOETINA DO ESTROMA TÍMICO aumenta no paciente com dermatite atópica?
When symptoms or doubts arise involving Atopic DermatitisDistinguishing between scientifically validated information and palliative care makes all the difference in the evolution of respiratory, skin, and systemic health. This page aims to deepen understanding of... "DERMATITE ATÓPICA — A LINFOPOETINA DO ESTROMA TÍMICO aumenta no paciente com dermatite atópica?", providing clear context on how the immune system reacts, which signs require medical attention, and how to structure individualized and effective care.
✔ Medical content reviewed and validated by the founding clinical staff of the Brazil Without Allergies Project
Dr. Marcello Bossois (CRM-RJ 52.73214-1) · Dr. Patricia Schlinkert (CRM/RJ 5274541-3) — more than 30 years of history in Allergy and Immunology, with units in Rio de Janeiro, São Paulo and Paraná. Last reviewed: November 2026.
O Papel da Linfopoetina do Estroma Tímico na Dermatite Atópica
A dermatite atópica é uma doença inflamatória crônica da pele que envolve mecanismos imunológicos complexos. Entre os fatores moleculares estudados na patogênese da condição, destaca-se a linfopoetina do estroma tímico (TSLP), uma substância produzida principalmente pelas células epiteliais da pele, os queratinócitos. Nos pacientes que apresentam quadros de dermatite atópica, os níveis dessa proteína encontram-se significativamente elevados, exercendo um papel crucial na manutenção e na gravidade do processo inflamatório.
A linfopoetina do estroma tímico atua como um importante sinalizador que ativa a resposta imunológica inata e promove a liberação de interleucinas específicas, com destaque para a interleucina-31 (IL-31). Essa citocina está diretamente relacionada à indução de processos alérgicos e, sobretudo, ao sintoma mais marcante e debilitante da dermatite atópica: o prurido intenso (coceira).
Por que os anti-histamínicos tradicionais podem não funcionar na coceira da dermatite atópica?
Um aspecto fundamental abordado no manejo clínico da dermatite atópica crônica é a compreensão de que a coceira característica da doença nem sempre decorre da liberação de histamina — substância tipicamente associada a alergias comuns e tratada com anti-histamínicos convencionais. Na dermatite atópica, o prurido é mediado predominantemente por vias neuro-imunes, como a ação da interleucina-31 sobre as microfibras nervosas cutâneas sensíveis.
Por essa razão, o uso isolado de anti-histamínicos frequentemente demonstra baixa eficácia no alívio da coceira em pacientes com dermatite atópica crônica. O tratamento adequado exige estratégias terapêuticas direcionadas, capazes de bloquear a sensibilização e a atividade dessas fibras finas responsáveis pela transmissão do impulso pruriginoso, além de controlar a inflamação subjacente da pele.
Cabe ressaltar que este conteúdo possui caráter estritamente educativo e informativo, não substituindo em hipótese alguma a consulta médica, o diagnóstico preciso e a elaboração de um plano de tratamento individualizado por um médico especialista, como um alergista, imunologista ou dermatologista.
Developments in Evidence-Based Medicine: Pathophysiology and Staged Management of Urticaria and Angioedema
In accordance with the international guideline EAACI/GA²LEN/EuroGuiDerm/APAAACI for the management of urticaria and angioedemaDegranulation of cutaneous mast cells with the release of histamine, platelet-activating factor (PAF), and cytokines promotes vasodilation, dermal plasma extravasation (fleeting pruritic papules/hives or submucosal/subcutaneous angioedema), and cell recruitment. To distinguish histaminergic angioedema from bradykinin-mediated angioedema (associated with C1-esterase inhibitor deficiency/dysfunction — C1-INH — or the use of ACE inhibitors), the presence of hives, the response to antihistamines, and the C4 and C1-INH levels are evaluated. First-line pharmacological treatment of chronic urticaria is based on non-sedating second-generation H1 antihistamines in standard doses, which can be increased up to four times the usual dose under medical prescription before the indication of anti-IgE immunobiological therapy.
💎 Diamond Plan — Peaceful skin, free from constant itching and sleepless flare-ups. Speak with an Allergy and Immunology specialist via teleconsultation, from anywhere in Brazil. Schedule a teleconsultation →
Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.
Skin Barrier Health, Immune Inflammation, and Pruritus Control
Epithelial Dysfunction, Skin Microbiome, and Delayed Sensitization
The skin acts as the first organ of immune defense in the human body. In atopic dermatitis, genetic alterations in structural proteins of the stratum corneum (such as filaggrin) and in the composition of ceramides cause transepidermal water loss, pronounced dryness, and facilitated entry of mites and aeroallergens. This microenvironment activates Th2 cytokines (especially IL-4, IL-13, and IL-31, directly linked to intense itching) and favors colonization by Staphylococcus aureus, whose superantigens perpetuate eczematous flare-ups.
Therapeutic Hydration, Skin Tests and Immunotherapy
Controlling the itch-scratch cycle requires ongoing management of subclinical inflammation through... tratamento de dermatite atópica, topical corticosteroid-sparing immunomodulators and administration of allergy test appropriate to the lesion profile. When household allergens play a significant role in worsening skin conditions, the indication for allergy vaccine It works by reducing immune hyper-reactivity and significantly spacing out relapses.
Diamond Plan: Specialized Allergy Treatment Wherever You Are
Living hundreds of miles from an allergist or having to interrupt treatment because of the price of vaccines shouldn't be anyone's fate. With the Diamond Plan, o Brasil Sem Alergia leva o mesmo padrão de cuidado de suas clínicas até a sua casa, com consultas por telemedicina e um caminho mais acessível para a imunoterapia. Uma pele em paz, sem coceira constante e sem crises que roubam o sono.
Why do patients across Brazil choose the Diamond Plan?
- Teleconsultation with a specialist In Allergy and Immunology, without queues and without long commutes — ideal for those who live far from large cities.
- easy access to Immunotherapy (including allergy vaccines and immunostimulants) — indicated for the treatment of allergic rhinitis, asthma, bronchitis, atopic dermatitis, insect/mosquito bite allergy (prurigo strophulus), recurrent candidiasis, and for increasing immunity in selected patients — capable of modifying the natural course of allergic disease, always through consultation and individualized prescription.
- A more accessible route For those facing the high cost of allergy vaccines, this plan offers support for continuity of treatment.
- Continuous monitoring based on clinical evolution, with adjustments to treatment throughout the entire therapeutic cycle.
- National coverage, backed by a consolidated physical network and a founding clinical team with over three decades of experience.
More than 30 years caring for people with allergies.
Founded and run by Dr. Marcello Bossois (CRM-RJ 52.73214-1) and by Dr. Patrícia Schlinkert (CRM/RJ 5274541-3)The Brazil Without Allergies Project adds... more than 30 years of history and more than 450,000 free services, with physical presence at Rio de Janeiro, São Paulo and Paraná, one mobile clinic bus that brings testing and consultations to communities with limited access to specialized care and a platform of telemedicine which connects patients from all states to the same standard of care.
START TODAY
Your expert consultation is just a click away.
I want to join the Diamond Plan.Schedule a teleconsultation
Official telemedicine environment: brasilsemalergia.online
Do you prefer to be served in person?
Our clinical units They conduct consultations, allergy tests, and immunotherapy follow-up with doctors in person:
- Rio de Janeiro: Realengo (West Zone), North Zone, Duke of Caxias, Xerém, New Iguaçu, Itaguaí, Niterói, Iguaba Grande and Saint Peter of the Village (Lakes Region).
- São Paulo: Campo Limpo (South Zone).
- Paraná: Curitiba.
Schedule your in-person appointment. Or check the mobile bus schedule through the customer service center on WhatsApp. (21) 99954-5632.
The indication for immunotherapy, and for any treatment, depends on an individual medical evaluation. This content is for informational purposes only and does not replace consultation with a specialist.
Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.
Conclusion and Summary of Guidelines
In summary, the appropriate approach to Atopic Dermatitis It requires a clear understanding of the immunological mechanisms involved, precise etiological diagnosis, and individualized medical follow-up. Avoiding self-medication and investigating the root cause of symptoms—relying on specialized resources and reliable guidance such as specialized allergy and immunology care when clinically relevant—is the safest way to control flare-ups, prevent complications, and ensure sustainable quality of life.
Scientific references and authoritative sources
The guidelines on this page follow the guidelines and literature of leading international Allergy and Immunology institutions. For further information:




